These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 23943562

  • 1. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
    Gao T, He B, Pan Y, Gu L, Chen L, Nie Z, Xu Y, Li R, Wang S.
    Clin Transl Oncol; 2014 Apr; 16(4):410-7. PubMed ID: 23943562
    [Abstract] [Full Text] [Related]

  • 2. Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression.
    Gao T, He B, Pan Y, Xu Y, Li R, Deng Q, Sun H, Wang S.
    Mol Carcinog; 2015 May; 54(5):359-67. PubMed ID: 24706416
    [Abstract] [Full Text] [Related]

  • 3. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Iwagami S, Yoshida N, Oki E, Morita M, Nakao M, Baba H.
    Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
    [Abstract] [Full Text] [Related]

  • 4. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
    Xu W, Fan H, He X, Zhang J, Xie W.
    J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
    [Abstract] [Full Text] [Related]

  • 5. Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients.
    Tian F, Tang Z, Song G, Pan Y, He B, Bao Q, Wang S.
    Mol Med Rep; 2012 Jun; 5(6):1536-40. PubMed ID: 22427002
    [Abstract] [Full Text] [Related]

  • 6. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of primary lung cancer in the central China region.
    Zhang M, Wu CH, Zhu XL, Wang YJ.
    Asian Pac J Cancer Prev; 2014 Jun; 15(18):7799-803. PubMed ID: 25292066
    [Abstract] [Full Text] [Related]

  • 7. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
    Ulaner GA, Vu TH, Li T, Hu JF, Yao XM, Yang Y, Gorlick R, Meyers P, Healey J, Ladanyi M, Hoffman AR.
    Hum Mol Genet; 2003 Mar 01; 12(5):535-49. PubMed ID: 12588801
    [Abstract] [Full Text] [Related]

  • 8. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
    Wu J, Qin Y, Li B, He WZ, Sun ZL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan 01; 38(1):49-52. PubMed ID: 17294726
    [Abstract] [Full Text] [Related]

  • 9. Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.
    Stier S, Neuhaus T, Albers P, Wernert N, Grünewald E, Forkert R, Vetter H, Ko Y.
    Arch Toxicol; 2006 Oct 01; 80(10):713-8. PubMed ID: 16721595
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
    Hidaka H, Higashimoto K, Aoki S, Mishima H, Hayashida C, Maeda T, Koga Y, Yatsuki H, Joh K, Noshiro H, Iwakiri R, Kawaguchi A, Yoshiura KI, Fujimoto K, Soejima H.
    Clin Epigenetics; 2018 Dec 04; 10(1):150. PubMed ID: 30509319
    [Abstract] [Full Text] [Related]

  • 11. Quantitative allele-specific expression and DNA methylation analysis of H19, IGF2 and IGF2R in the human placenta across gestation reveals H19 imprinting plasticity.
    Buckberry S, Bianco-Miotto T, Hiendleder S, Roberts CT.
    PLoS One; 2012 Dec 04; 7(12):e51210. PubMed ID: 23227253
    [Abstract] [Full Text] [Related]

  • 12. Placenta-specific epimutation at H19-DMR among common pregnancy complications: its frequency and effect on the expression patterns of H19 and IGF2.
    Yamaguchi Y, Tayama C, Tomikawa J, Akaishi R, Kamura H, Matsuoka K, Wake N, Minakami H, Kato K, Yamada T, Nakabayashi K, Hata K.
    Clin Epigenetics; 2019 Aug 01; 11(1):113. PubMed ID: 31370882
    [Abstract] [Full Text] [Related]

  • 13. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
    Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP.
    Cancer Res; 2002 Nov 15; 62(22):6442-6. PubMed ID: 12438232
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.
    Zhang H, Shi X, Chang W, Li Y, Wang L, Wang L.
    Mol Med Rep; 2018 Feb 15; 17(2):2251-2256. PubMed ID: 29207103
    [Abstract] [Full Text] [Related]

  • 15. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases.
    Kim SJ, Park SE, Lee C, Lee SY, Kim IH, An HJ, Oh YK.
    Gynecol Oncol; 2003 Mar 15; 88(3):411-8. PubMed ID: 12648595
    [Abstract] [Full Text] [Related]

  • 16. Loss of Igf2 imprinting in monoclonal mouse hepatic tumor cells is not associated with abnormal methylation patterns for the H19, Igf2, and Kvlqt1 differentially methylated regions.
    Ishizaki T, Yoshie M, Yaginuma Y, Tanaka T, Ogawa K.
    J Biol Chem; 2003 Feb 21; 278(8):6222-8. PubMed ID: 12475990
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction.
    Tabano S, Colapietro P, Cetin I, Grati FR, Zanutto S, Mandò C, Antonazzo P, Pileri P, Rossella F, Larizza L, Sirchia SM, Miozzo M.
    Epigenetics; 2010 May 16; 5(4):313-24. PubMed ID: 20418667
    [Abstract] [Full Text] [Related]

  • 18. Genomic imprinting of IGF2 and H19 in human meningiomas.
    Müller S, Zirkel D, Westphal M, Zumkeller W.
    Eur J Cancer; 2000 Mar 16; 36(5):651-5. PubMed ID: 10738131
    [Abstract] [Full Text] [Related]

  • 19. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas.
    Rainho CA, Kowalski LP, Rogatto SR.
    Head Neck; 2001 Oct 16; 23(10):851-9. PubMed ID: 11592232
    [Abstract] [Full Text] [Related]

  • 20. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II.
    Kim SJ, Park SE, Lee C, Lee SY, Jo JH, Kim JM, Oh YK.
    Biochim Biophys Acta; 2002 Apr 24; 1586(3):307-15. PubMed ID: 11997082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.